Actively Recruiting
Efficacy and Safety of Electroacupuncture for ICU Sepsis Patients
Led by Shusheng Li · Updated on 2025-04-18
308
Participants Needed
1
Research Sites
80 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy and safety of electroacupuncture (EA) combined with standard Intensive Care Unit (ICU) therapy on organ dysfunction and other clinical outcomes in sepsis patients. Additionally, this study will conduct subgroup analyses to investigate the influence of septic shock and immunomodulators on the treatment effects and their correlation with electroacupuncture efficacy.
CONDITIONS
Official Title
Efficacy and Safety of Electroacupuncture for ICU Sepsis Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosed with sepsis as defined by an increase of 2 or more points in SOFA score due to infection or suspected infection
- Patient or legal representative understands and voluntarily signs informed consent
You will not qualify if you...
- Lower extremity denervation
- Lower extremity amputation or congenital lower limb disability
- Severe acute trauma such as active bleeding or unstable fractures in lower extremities
- Skin damage, infection, bleeding, or hematoma near lower leg acupuncture sites
- Presence of implantable medical devices like pacemakers, implantable cardioverter defibrillators, or deep brain stimulators
- Pregnant or breastfeeding during the study
- Expected ICU stay less than 48 hours
- Legal representatives refuse active treatment and sign palliative care consent
- Currently enrolled in another randomized clinical trial
- Patient or legal representative refuses or is unable to sign informed consent
- Immunosuppressive conditions including congenital immunodeficiency, AIDS, organ transplant, long-term immunosuppressive use, recent tumor radiotherapy or chemotherapy within 1 month
- Anticipated survival prognosis of 7 days or less due to advanced disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030
Actively Recruiting
Research Team
S
Shusheng Li, PhD.
CONTACT
Y
Yi Bian, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here